Pavel Santos
I'm really impressed with the services provided by Rbv invest aps. They have been prompt and efficient in addressing my queries. Their expertise and professionalism is commendable. 👍
Jane Longden
I had an overall positive experience with this company. They were professional and efficient. However, there were some areas that could be improved. Nevertheless, I appreciate their efforts.
Sohin Shah
Rbv invest aps has been a reliable partner for my business. Their team is knowledgeable and has provided excellent support. I am satisfied with their services and would recommend them.
Jason Day
I recently used the services of this company and I'm pleased with the outcome. The team was helpful and provided valuable insights. I would consider using their services again in the future.
Jennifer Mavashev
I had a great experience with Rbv invest aps. Their team was very professional and knowledgeable. They provided excellent advice and guidance throughout the entire process. I highly recommend their services.
Beverly Byers
The services provided by this company were exceptional. The team was very helpful and attentive to my needs. They went above and beyond to ensure a smooth and successful experience. Highly recommended.
EASLEY ASHTON
The team at Rbv invest aps has been outstanding. They have exceeded my expectations with their services. Their professionalism and expertise are truly commendable. Highly recommended!
Paul Dadd
I am happy with the services provided by Rbv invest aps. They have been prompt in answering my queries and have provided valuable assistance. 👍
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Rbv invest aps
Interested in bringing the power of the lab right to the point of need? Our instrument-free rapid, single-use PCR test may be used at any site with a CLIA certificate of waiver.
RBV Invest ApS: Revolutionizing Point-of-Care Testing with Instrument-Free PCR Tests
RBV Invest ApS is a Danish biotech company that specializes in developing innovative solutions for point-of-care testing. The company's flagship product is an instrument-free rapid, single-use PCR test that can be used at any site with a CLIA certificate of waiver. This breakthrough technology has the potential to revolutionize the way we diagnose and treat diseases, especially in resource-limited settings.
At RBV Invest ApS, we believe that access to accurate and timely diagnostic information is critical for improving patient outcomes and reducing healthcare costs. However, traditional laboratory-based testing methods are often slow, expensive, and require specialized equipment and trained personnel. This can be a major barrier to effective diagnosis and treatment, particularly in remote or underserved areas.
To address this challenge, RBV Invest ApS has developed an innovative solution that brings the power of the lab right to the point of need. Our instrument-free rapid PCR test uses a proprietary amplification technology that enables highly sensitive detection of nucleic acid targets without the need for thermal cycling or other complex instrumentation.
This means that our test can be performed on-site by non-expert users using only a simple heating device such as a hot plate or water bath. The results are available within 30 minutes and can be read visually or using a smartphone app.
Our instrument-free PCR test has been validated for use in detecting various infectious agents such as SARS-CoV-2 (COVID-19), influenza A/B virus, respiratory syncytial virus (RSV), human papillomavirus (HPV), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycobacterium tuberculosis (MTB) complex DNA/RNA etc., making it suitable for use in various clinical settings including hospitals, clinics, pharmacies etc.
In addition to its speed and simplicity, our instrument-free PCR test offers several other advantages over traditional laboratory-based testing methods. For example, it requires minimal sample preparation and can be performed using a wide range of sample types including nasopharyngeal swabs, saliva, urine etc. This makes it ideal for use in settings where sample collection and transport may be challenging.
Furthermore, our test is highly specific and sensitive with a limit of detection as low as 10 copies/reaction for some targets. This means that it can detect even low levels of viral or bacterial DNA/RNA that may be missed by other diagnostic methods.
At RBV Invest ApS, we are committed to advancing the field of point-of-care testing through innovation and collaboration. We work closely with healthcare providers, researchers, and industry partners to develop new solutions that meet the evolving needs of patients and healthcare systems worldwide.
If you are interested in learning more about our instrument-free rapid PCR test or partnering with us to bring this technology to market, please contact us today!